Matrix-induced endochondral bone differentiation: Influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone

A Hari Reddi, N. E. Sullivan

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

The influence of hypophysectomy (hypox), GH, and TSH on the discrete phases of matrix-induced endochondral bone differentiation was investigated. [3H]Thymidine incorporation by proliferating mesenchymal cells on day 3 was inhibited by hypox, but was corrected by GH administration. On day 7, 35SO4 incorporation into cartilage proteoglycans was reduced by hypox, but was restored to values higher than controls by GH. Calcification of cartilage and bone was monitored by alkaline phosphatase activity, 45Ca incorporation into bone mineral, and total calcium. Alkaline phosphatase levels were maximal on day 11 in the controls and declined thereafter; however, the activity of alkaline phosphatase remained elevated in hypox recipients. Hypox reduced and delayed the rate and extent of calcification, as reflected by 45Ca incorporation and total calcium, respectively. The administration of GH and TSH alone and in combination restored 45Ca incorporation to control values in tibial metaphyses but not in the matrix-induced osteogenic plaques on day 10. These findings imply that the hormonal requirements for initiation of de novo mineralization of bone may be different from those required for the maintenance of mineralization that was initiated in early fetal life, as in the case of metaphyses. Hypox resulted in a delayed and reduced bone formation due to 1) inhibition of mesenchymal cell proliferation, 2) decreased and delayed chondrogenesis, 3) delayed and reduced vascular invasion, and 4) impaired bone formation.

Original languageEnglish (US)
Pages (from-to)1291-1299
Number of pages9
JournalEndocrinology
Volume107
Issue number5
StatePublished - 1980
Externally publishedYes

Fingerprint

Hypophysectomy
Thyrotropin
Growth Hormone
Bone and Bones
Alkaline Phosphatase
Osteogenesis
Cartilage
Calcium
Chondrogenesis
Physiologic Calcification
Proteoglycans
Thymidine
Minerals
Blood Vessels
olifen
Maintenance
Cell Proliferation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Matrix-induced endochondral bone differentiation : Influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. / Reddi, A Hari; Sullivan, N. E.

In: Endocrinology, Vol. 107, No. 5, 1980, p. 1291-1299.

Research output: Contribution to journalArticle

@article{7eb3388335c44d6caa996a1a0971a30d,
title = "Matrix-induced endochondral bone differentiation: Influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone",
abstract = "The influence of hypophysectomy (hypox), GH, and TSH on the discrete phases of matrix-induced endochondral bone differentiation was investigated. [3H]Thymidine incorporation by proliferating mesenchymal cells on day 3 was inhibited by hypox, but was corrected by GH administration. On day 7, 35SO4 incorporation into cartilage proteoglycans was reduced by hypox, but was restored to values higher than controls by GH. Calcification of cartilage and bone was monitored by alkaline phosphatase activity, 45Ca incorporation into bone mineral, and total calcium. Alkaline phosphatase levels were maximal on day 11 in the controls and declined thereafter; however, the activity of alkaline phosphatase remained elevated in hypox recipients. Hypox reduced and delayed the rate and extent of calcification, as reflected by 45Ca incorporation and total calcium, respectively. The administration of GH and TSH alone and in combination restored 45Ca incorporation to control values in tibial metaphyses but not in the matrix-induced osteogenic plaques on day 10. These findings imply that the hormonal requirements for initiation of de novo mineralization of bone may be different from those required for the maintenance of mineralization that was initiated in early fetal life, as in the case of metaphyses. Hypox resulted in a delayed and reduced bone formation due to 1) inhibition of mesenchymal cell proliferation, 2) decreased and delayed chondrogenesis, 3) delayed and reduced vascular invasion, and 4) impaired bone formation.",
author = "Reddi, {A Hari} and Sullivan, {N. E.}",
year = "1980",
language = "English (US)",
volume = "107",
pages = "1291--1299",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Matrix-induced endochondral bone differentiation

T2 - Influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone

AU - Reddi, A Hari

AU - Sullivan, N. E.

PY - 1980

Y1 - 1980

N2 - The influence of hypophysectomy (hypox), GH, and TSH on the discrete phases of matrix-induced endochondral bone differentiation was investigated. [3H]Thymidine incorporation by proliferating mesenchymal cells on day 3 was inhibited by hypox, but was corrected by GH administration. On day 7, 35SO4 incorporation into cartilage proteoglycans was reduced by hypox, but was restored to values higher than controls by GH. Calcification of cartilage and bone was monitored by alkaline phosphatase activity, 45Ca incorporation into bone mineral, and total calcium. Alkaline phosphatase levels were maximal on day 11 in the controls and declined thereafter; however, the activity of alkaline phosphatase remained elevated in hypox recipients. Hypox reduced and delayed the rate and extent of calcification, as reflected by 45Ca incorporation and total calcium, respectively. The administration of GH and TSH alone and in combination restored 45Ca incorporation to control values in tibial metaphyses but not in the matrix-induced osteogenic plaques on day 10. These findings imply that the hormonal requirements for initiation of de novo mineralization of bone may be different from those required for the maintenance of mineralization that was initiated in early fetal life, as in the case of metaphyses. Hypox resulted in a delayed and reduced bone formation due to 1) inhibition of mesenchymal cell proliferation, 2) decreased and delayed chondrogenesis, 3) delayed and reduced vascular invasion, and 4) impaired bone formation.

AB - The influence of hypophysectomy (hypox), GH, and TSH on the discrete phases of matrix-induced endochondral bone differentiation was investigated. [3H]Thymidine incorporation by proliferating mesenchymal cells on day 3 was inhibited by hypox, but was corrected by GH administration. On day 7, 35SO4 incorporation into cartilage proteoglycans was reduced by hypox, but was restored to values higher than controls by GH. Calcification of cartilage and bone was monitored by alkaline phosphatase activity, 45Ca incorporation into bone mineral, and total calcium. Alkaline phosphatase levels were maximal on day 11 in the controls and declined thereafter; however, the activity of alkaline phosphatase remained elevated in hypox recipients. Hypox reduced and delayed the rate and extent of calcification, as reflected by 45Ca incorporation and total calcium, respectively. The administration of GH and TSH alone and in combination restored 45Ca incorporation to control values in tibial metaphyses but not in the matrix-induced osteogenic plaques on day 10. These findings imply that the hormonal requirements for initiation of de novo mineralization of bone may be different from those required for the maintenance of mineralization that was initiated in early fetal life, as in the case of metaphyses. Hypox resulted in a delayed and reduced bone formation due to 1) inhibition of mesenchymal cell proliferation, 2) decreased and delayed chondrogenesis, 3) delayed and reduced vascular invasion, and 4) impaired bone formation.

UR - http://www.scopus.com/inward/record.url?scp=0018970448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018970448&partnerID=8YFLogxK

M3 - Article

C2 - 7428672

AN - SCOPUS:0018970448

VL - 107

SP - 1291

EP - 1299

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -